000 01426 a2200433 4500
005 20250513062023.0
264 0 _c19940414
008 199404s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1994.109
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOgilvie, A C
245 0 0 _aA pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.
_h[electronic resource]
260 _bBritish journal of cancer
_cMar 1994
300 _a596-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCarcinoma, Renal Cell
_xblood
650 0 4 _aComplement C1 Inactivator Proteins
_xadministration & dosage
650 0 4 _aComplement C3a
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInterleukin-2
_xtoxicity
650 0 4 _aKidney Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMelanoma
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
700 1 _aBaars, J W
700 1 _aEerenberg, A J
700 1 _aHack, C E
700 1 _aPinedo, H M
700 1 _aThijs, L G
700 1 _aWagstaff, J
773 0 _tBritish journal of cancer
_gvol. 69
_gno. 3
_gp. 596-8
856 4 0 _uhttps://doi.org/10.1038/bjc.1994.109
_zAvailable from publisher's website
999 _c8122818
_d8122818